Trexquant Investment’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Trexquant Investment’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-19,298	Closed	-$389K	–	1752
2021 Q3	$389K	Buy	19,298 +12,323	+177%	+$340K	0.03%	636
2021 Q2	$260K	Buy	+6,975	New	+$214K	0.02%	784
2020 Q4	–	Sell	-26,474	Closed	-$476K	–	1642
2020 Q3	$476K	Sell	26,474 -10,003	-27%	-$207K	0.03%	713
2020 Q2	$927K	Buy	36,477 +17,070	+88%	+$368K	0.06%	423
2020 Q1	$357K	Buy	19,407 +3,168	+20%	+$61.6K	0.03%	784
2019 Q4	$358K	Buy	+16,239	New	+$327K	0.02%	680
2019 Q1	–	Sell	-10,366	Closed	-$111K	–	1422
2018 Q4	$111K	Buy	+10,366	New	+$136K	0.01%	986

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Trexquant Investment's DRNA Position: Q4 2021 in Review

Trexquant Investment sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 19,298 shares — an estimated $389K sold.

Trexquant Investment first reported a position in DRNA in Q4 2018 and held it in 7 quarters. The position peaked at $927K in Q2 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Trexquant Investment reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Trexquant Investment sold 19,298 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $389K.
Trexquant Investment first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2018 and held it in 7 quarters.
Trexquant Investment's Dicerna Pharmaceuticals, Inc. position peaked at $927K in Q2 2020.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Trexquant Investment's 13F filing for Q4 2021, filed 14 Feb 2022.